Is Durrant getting an even bigger bang for his drug development bucks? I like the fact that Dale sold his Baudax shares, but that Intracoastal bought shares in the same time period. Will this present an opportunity for us regarding Tera-Immune?
Much more importantly, I see where Novavax announced today that they have entered into a Settlement Agreement with Gavi, regarding an Advanced Purchase Agreement.
The event that I am most looking forward to is the recall of our loaned shares, which may give me a brief moment to sell shares into a short squeeze.
But, the potential partnership that I am most looking forward to would be a stock-for-stock transaction with Novavax in a merger or business combination. I think that could lead to sustained annual revenue of over $67 per share, giving us a Market Cap in the $8B range.
The Gavi settlement greatly improves the outlook for Novavax to survive, and I hope it will prove another of the requirements for Humanigen to proceed with this venture (the first requirement was to significantly reduce R&D expense, which they have done). With the current institutional interest in Novavax, I am very excited about a possible pending announcement about a partnership with us.